Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABH HealthcareNSE:ABH -16.56%15 Return-on-Tangible-Equity is 69.44% as of Mar. 2025, which is 78% above its 10-year median of 39.11. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 592 Healthcare Providers & Services companies, ABH Healthcare ranks better than 80.24% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. ABH Healthcare's annualized net income for the quarter that ended in Mar. 2025 was ₹ Mil. ABH Healthcare's average shareholder tangible equity for the quarter that ended in Mar. 2025 was ₹ Mil. Therefore, ABH Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 was %.
The historical rank and industry rank for ABH Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
NSE:ABH'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 30.23 Med: 39.11 Max: 93
Current: 39.11
During the past 4 years, ABH Healthcare's highest Return-on-Tangible-Equity was 93.00%. The lowest was 30.23%. And the median was 39.11%.
NSE:ABH's Return-on-Tangible-Equity is ranked better than 80.24% of 592
companies
in the Healthcare Providers & Services industry
Industry Median: 10.72
vs NSE:ABH: 39.11
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
ABH Healthcare Return-on-Tangible-Equity Related Terms
ABH Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for ABH Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABH Healthcare Return-on-Tangible-Equity Chart
ABH Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Return-on-Tangible-Equity
93.00
30.23
38.70
57.34
ABH Healthcare Quarterly Data
Mar25
Return-on-Tangible-Equity
69.44
NSE:ABH vs : Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, ABH Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABH Healthcare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where ABH Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 69.44% mean?
ABH Healthcare (NSE:ABH) has a Return-on-Tangible-Equity of 69.44% as of Mar. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ABH Healthcare and its competitors. This is 78% above median its historical median of 39.11. Over the past decade, ABH Healthcare's Return-on-Tangible-Equity has ranged from 30.23 to 93.00. According to the industry distribution chart, ABH Healthcare ranks #117 out of 592 companies in the Healthcare Providers & Services industry, placing it in the top 19.8%.
Is ABH Healthcare's Return-on-Tangible-Equity too high?
ABH Healthcare's current Return-on-Tangible-Equity of 69.44% is 78% above median its 10-year median of 39.11. Over the past 10 years, this metric has ranged from a low of 30.23 to a high of 93.00. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.72. ABH Healthcare's value of 69.44% is 547.8% above this industry median. Based on the distribution chart, ABH Healthcare ranks #117 out of 592 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's Return-on-Tangible-Equity compare to ?
According to the Healthcare Providers & Services industry distribution chart, ABH Healthcare ranks #117 out of 592 companies for Return-on-Tangible-Equity. This places ABH Healthcare in the top 20% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.72. ABH Healthcare's value of 69.44% is 547.8% above this benchmark. Historically, ABH Healthcare's own Return-on-Tangible-Equity has ranged from 30.23 to 93.00 over the past decade. While the company's 10-year median is 39.11 vs. the industry median of 10.72, ABH Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.72, based on 592 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABH Healthcare's current Return-on-Tangible-Equity of 69.44% is 547.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ABH Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABH Healthcare's current Return-on-Tangible-Equity is 69.44%, which is 78% above median its own 10-year median of 39.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current Return-on-Tangible-Equity of 69.44%. The current Return-on-Tangible-Equity is 69.44%, which is 78% above median its 10-year median of 39.11 and 547.8% above the Healthcare Providers & Services industry median of 10.72. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current Return-on-Tangible-Equity is 69.44% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score
Get the complete analysis for NSE:ABH
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ABH has been successfully added to your 
